ANTIZOL-VET DIN 02249952
Health Canada record
| Active ingredient(s) | FOMEPIZOLE 1 G |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | |
| Current status date | 28-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Paladin Pharma Inc. — licence 100234, currently licensed, last inspection rating C (2023-04-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FOMEPIZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02242980 | ANTIZOL | KNIGHT THERAPEUTICS INC. | Liquid | FOMEPIZOLE 1 G | Marketed |
| 02435667 | FOMEPIZOLE FOR INJECTION | STERIMAX INC | Solution | FOMEPIZOLE 1 G | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9202 | 2007-11-27 | Supplement to a New Drug Submission (SNDS) | CHANGE IN PACKAGING AND DILUTION INSTRUCTION |
| 9049 | 2007-09-24 | Supplement to a New Drug Submission (SNDS) | ALTERNATE MANUFACTURING SITE |
| 8802 | 2007-05-25 | New Drug Submission (NDS) | |
| 71 | 2004-03-10 | New Drug Submission (NDS) |
International API supply for FOMEPIZOLE
8 active FDA Drug Master Files.
Request a quote for ANTIZOL-VET